Cargando…

Predicting HIV-1 transmission and antibody neutralization efficacy in vivo from stoichiometric parameters

The potential of broadly neutralizing antibodies targeting the HIV-1 envelope trimer to prevent HIV-1 transmission has opened new avenues for therapies and vaccines. However, their implementation remains challenging and would profit from a deepened mechanistic understanding of HIV-antibody interacti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brandenberg, Oliver F., Magnus, Carsten, Rusert, Peter, Günthard, Huldrych F., Regoes, Roland R., Trkola, Alexandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5417720/ https://www.ncbi.nlm.nih.gov/pubmed/28472201 http://dx.doi.org/10.1371/journal.ppat.1006313

Ejemplares similares

Partial rescue of V1V2 mutant infectivity by HIV-1 cell-cell transmission supports the domain’s exceptional capacity for sequence variation
por: Brandenberg, Oliver F, et al.
Publicado: (2014)

Interaction of the gp120 V1V2 loop with a neighboring gp120 unit shields the HIV envelope trimer against cross-neutralizing antibodies
por: Rusert, Peter, et al.
Publicado: (2011)

MPER-specific antibodies induce gp120 shedding and irreversibly neutralize HIV-1
por: Ruprecht, Claudia R., et al.
Publicado: (2011)

Different Infectivity of HIV-1 Strains Is Linked to Number of Envelope Trimers Required for Entry
por: Brandenberg, Oliver F., et al.
Publicado: (2015)

Cell-Cell Transmission Enables HIV-1 to Evade Inhibition by Potent CD4bs Directed Antibodies
por: Abela, Irene A., et al.
Publicado: (2012)

Capacity of Broadly Neutralizing Antibodies to Inhibit HIV-1 Cell-Cell Transmission Is Strain- and Epitope-Dependent
por: Reh, Lucia, et al.
Publicado: (2015)

Reply to correspondence ‘Conserved signatures indicate HIV-1 transmission is under strong selection and thus is not a “stochastic” process’ by Gonzalez et al., Retrovirology 2017
por: Oberle, Corinna S., et al.
Publicado: (2017)

HIV-1 replication activates CD4(+) T cells with specificities for persistent herpes viruses
por: Haas, Anna, et al.
Publicado: (2010)

Estimating the Stoichiometry of HIV Neutralization
por: Magnus, Carsten, et al.
Publicado: (2010)

P04-40. Dissecting pre- and post-attachment activity of HIV-1 entry inhibitors and neutralizing antibodies
por: Berlinger, L, et al.
Publicado: (2009)

OMIP‐047: High‐Dimensional phenotypic characterization of B cells
por: Liechti, Thomas, et al.
Publicado: (2018)

Delineating CD4 dependency of HIV-1: Adaptation to infect low level CD4 expressing target cells widens cellular tropism but severely impacts on envelope functionality
por: Beauparlant, David, et al.
Publicado: (2017)

Tracing HIV-1 transmission: envelope traits of HIV-1 transmitter and recipient pairs
por: Oberle, Corinna S., et al.
Publicado: (2016)

Distinct, IgG1-driven antibody response landscapes demarcate individuals with broadly HIV-1 neutralizing activity
por: Kadelka, Claus, et al.
Publicado: (2018)

P09-02. Selection pressure of neutralizing antibodies and viral escape continues in late stages of the disease
por: Rusert, P, et al.
Publicado: (2009)

Distinct conformations of the HIV-1 V3 loop crown are targetable for broad neutralization
por: Friedrich, Nikolas, et al.
Publicado: (2021)

Disentangling Human Tolerance and Resistance Against HIV
por: Regoes, Roland R., et al.
Publicado: (2014)

Widespread B cell perturbations in HIV-1 infection afflict naive and marginal zone B cells
por: Liechti, Thomas, et al.
Publicado: (2019)

Phenotypic deficits in the HIV-1 envelope are associated with the maturation of a V2-directed broadly neutralizing antibody lineage
por: Reh, Lucia, et al.
Publicado: (2018)

Using an Epidemiological Model for Phylogenetic Inference Reveals Density Dependence in HIV Transmission
por: Leventhal, Gabriel E., et al.
Publicado: (2014)

HIV-1 Subtype C, Tenofovir, and the Relationship With Treatment Failure and Drug Resistance
por: Günthard, Huldrych F., et al.
Publicado: (2016)

High-Throughput Sequencing of Human Immunoglobulin Variable Regions with Subtype Identification
por: Schanz, Merle, et al.
Publicado: (2014)

P02-09. Dissecting the interference of endotoxins with HIV infection of primary CD4 T cell
por: Krarup, A, et al.
Publicado: (2009)

Broadly neutralizing antibodies: What is needed to move from a rare event in HIV-1 infection to vaccine efficacy?
por: Subbaraman, Harini, et al.
Publicado: (2018)

Do we cause false positives? An experimental series on droplet or airborne SARS-CoV-2 contamination of sampling tubes during swab collection in a test center
por: Scheier, Thomas, et al.
Publicado: (2021)

Seroprofiling of Antibodies Against Endemic Human Coronaviruses and Severe Acute Respiratory Syndrome Coronavirus 2 in a Human Immunodeficiency Virus Cohort in Lesotho: Correlates of Antibody Response and Seropositivity
por: Brown, Jennifer A, et al.
Publicado: (2023)

Complement Lysis Activity in Autologous Plasma Is Associated with Lower Viral Loads during the Acute Phase of HIV-1 Infection
por: Huber, Michael, et al.
Publicado: (2006)

Antibodies from convalescent plasma promote SARS-CoV-2 clearance in individuals with and without endogenous antibody response
por: Marconato, Maddalena, et al.
Publicado: (2022)

Editorial Commentary: The Irreversibility of HIV Drug Resistance
por: Kouyos, Roger D., et al.
Publicado: (2015)

Assessment of Overlap of Phylogenetic Transmission Clusters and Communities in Simple Sexual Contact Networks: Applications to HIV-1
por: Villandre, Luc, et al.
Publicado: (2016)

Tailored enrichment strategy detects low abundant small noncoding RNAs in HIV-1 infected cells
por: Althaus, Claudia F, et al.
Publicado: (2012)

Analysis of the Subunit Stoichiometries in Viral Entry
por: Magnus, Carsten, et al.
Publicado: (2012)

P04-37. Kinetic and thermodynamic factors determine HIV-1 neutralizing potency of MPER-specific antibodies
por: Ruprecht, C, et al.
Publicado: (2009)

Assessing immunogenicity barriers of the HIV-1 envelope trimer
por: Maliqi, Liridona, et al.
Publicado: (2023)

IFITM3 incorporation sensitizes influenza A virus to antibody-mediated neutralization
por: Lanz, Caroline, et al.
Publicado: (2021)

Inferring the age difference in HIV transmission pairs by applying phylogenetic methods on the HIV transmission network of the Swiss HIV Cohort Study
por: Kusejko, Katharina, et al.
Publicado: (2018)

CD4 occupancy triggers sequential pre-fusion conformational states of the HIV-1 envelope trimer with relevance for broadly neutralizing antibody activity
por: Ivan, Branislav, et al.
Publicado: (2019)

Two Years of Viral Metagenomics in a Tertiary Diagnostics Unit: Evaluation of the First 105 Cases
por: Kufner, Verena, et al.
Publicado: (2019)

Structure of HIV-1 gp41 with its membrane anchors targeted by neutralizing antibodies
por: Caillat, Christophe, et al.
Publicado: (2021)

Lack of protection in vivo with neutralizing monoclonal antibodies to transmissible gastroenteritis virus
por: Wesley, R.D., et al.
Publicado: (1988)

Cannot write session to /tmp/vufind_sessions/sess_r2d83qi7l16284ohf49bso37hc